TABLE 1 AGEING WORLD POPULATION
TABLE 2 POSTOPERATIVE PULMONARY EMBOLISM OR DEEP VEIN THROMBOSIS IN HIP AND KNEE SURGERIES, 2015
TABLE 3 GLOBAL ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 4 GLOBAL DEEP VEIN THROMBOSIS (DVT) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 GLOBAL PULMONARY EMBOLISM (PE) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 6 GLOBAL ARTERIAL THROMBOEMBOLISM (AT) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 7 GLOBAL STROKE IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 8 GLOBAL OTHERS IN GLOBAL ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 GLOBAL ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 10 GLOBAL NOVEL ORAL ANTICOAGUALTANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 GLOBAL NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 12 GLOBAL HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 GLOBAL HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 14 GLOBAL VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 GLOBAL VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 16 GLOBAL OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 GLOBAL ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 18 GLOBAL BIVALIRUDIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 GLOBAL DABIGATRAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 20 GLOBAL EDOXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 GLOBAL BETRIXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 GLOBAL RIVAROXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 GLOBAL APIXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 24 GLOBAL ENOXAPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 25 GLOBAL DALTEPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 GLOBAL OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 27 GLOBAL ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION , 2017-2026 (USD MILLION)
TABLE 28 GLOBAL ORAL IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 GLOBAL INJECTABLES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 30 GLOBAL INJECTABLES IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 31 GLOBAL ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 32 GLOBAL CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 GLOBAL CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 34 GLOBAL ONCOLOGY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 35 GLOBAL RESPIRATORY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 36 GLOBAL NEPHROLOGY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 37 GLOBAL CNS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 38 GLOBAL OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 39 GLOBAL ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 40 GLOBAL PRE-SURGICAL PROCEDURES IN GLOBAL ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 41 GLOBAL POST-SURGICAL PROCEDURES IN GLOBAL ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 42 GLOBAL KIDNEY DIALYSIS IN GLOBAL ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 43 GLOBAL HEART VALVE REPLACEMENT IN GLOBAL ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 44 GLOBAL ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 45 GLOBAL GENERICS IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 46 GLOBAL BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 47 GLOBAL BRANDED IN GLOBAL ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 48 GLOBAL ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 49 GLOBAL HOSPITALS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 50 GLOBAL CLINICS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 51 GLOBAL HOMECARE IN ANTICOAGULATION THERAPY MARKET,BY REGION, 2017-2026 (USD MILLION)
TABLE 52 GLOBAL AMBULATORY SURGICAL CENTERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 53 GLOBAL OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 54 GLOBAL ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 55 GLOBAL HOSPITAL PHARMACY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 56 RETAIL PHARMACIES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 57 GLOBAL ONLINE PHARMACIES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 58 GLOBAL ANTICOAGULATION THERAPY MARKET, BY GEOGRAPHY, 2017-2026 (USD MILLION)
TABLE 59 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 60 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 61 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 62 NORTH AMERICA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 63 NORTH AMERICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 64 NORTH AMERICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 65 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 66 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 67 NORTH AMERICA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 68 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 69 NORTH AMERICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 70 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 71 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 72 NORTH AMERICA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 73 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 74 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 75 U.S. ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 76 U.S. ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 77 U.S. NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 78 U.S. HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 79 U.S. VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 80 U.S. ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 81 U.S. ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 82 U.S. INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 83 U.S.ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 84 U.S. CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 85 U.S. ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 86 U.S. ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 87 U.S. BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 88 U.S. ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 89 U.S. ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 90 CANADA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 91 CANADA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 92 CANADA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 93 CANADA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 94 CANADA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 95 CANADA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 96 CANADA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 97 CANADA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 98 CANADA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 99 CANADA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 100 CANADA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 101 CANADA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 102 CANADA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 103 CANADA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 104 CANADA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 105 MEXICO ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 106 MEXICO ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 107 MEXICO NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 108 MEXICO HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 109 MEXICO VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 110 MEXICO ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 111 MEXICO ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 112 MEXICO INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 113 MEXICO ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 114 MEXICO CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 115 MEXICO ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 116 MEXICO ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 117 MEXICO BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 118 MEXICO ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 119 MEXICO ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 120 EUROPE ANTICOAGULATION THERAPY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 121 EUROPE ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 122 EUROPE ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 123 EUROPE NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 124 EUROPE HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 125 EUROPE VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 126 EUROPE ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 127 EUROPE ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 128 EUROPE INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 129 EUROPE ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 130 EUROPE CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 131 EUROPE ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 132 EUROPE ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 133 EUROPE BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION))
TABLE 134 EUROPE ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 135 EUROPE ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 136 GERMANY ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 137 GERMANY ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 138 GERMANY NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 139 GERMANY HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 140 GERMANY VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 141 GERMANY ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 142 GERMANY ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 143 GERMANY INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 144 GERMANY ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 145 GERMANY CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 146 GERMANY ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 147 GERMANY ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 148 GERMANY BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 149 GERMANY ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 150 GERMANY ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 151 FRANCE ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 152 FRANCE ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 153 FRANCE NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 154 FRANCE HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 155 FRANCE VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 156 FRANCE ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 157 FRANCE ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 158 FRANCE INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 159 FRANCE ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 160 FRANCE CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 161 FRANCE ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 162 FRANCE ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 163 FRANCE BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 164 FRANCE ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 165 FRANCE ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 166 ITALY ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 167 ITALY ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 168 ITALY NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 169 ITALY HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 170 ITALY VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 171 ITALY ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 172 ITALY ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 173 ITALY INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 174 ITALY ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 175 ITALY CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 176 ITALY ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 177 ITALY ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 178 ITALY BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 179 ITALY ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 180 ITALY ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 181 U.K. ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 182 U.K. ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 183 U.K. NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 184 U.K. HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 185 U.K. VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 186 U.K. ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 187 U.K. ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 188 U.K. INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 189 U.K. ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 190 U.K. CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 191 U.K. ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 192 U.K. ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 193 U.K. BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 194 U.K. ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 195 U.K. ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 196 SPAIN ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 197 SPAIN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 198 SPAIN NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 199 SPAIN HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 200 SPAIN VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 201 SPAIN ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 202 SPAIN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 203 SPAIN INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 204 SPAIN ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 205 SPAIN CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 206 SPAIN ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 207 SPAIN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 208 SPAIN BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 209 SPAIN ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 210 SPAIN ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 211 SWITZERLAND ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 212 SWITZERLAND ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 213 SWITZERLAND NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 214 SWITZERLAND HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 215 SWITZERLAND VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 216 SWITZERLAND ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 217 SWITZERLAND ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 218 SWITZERLAND INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 219 SWITZERLAND ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 220 SWITZERLAND CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 221 SWITZERLAND ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 222 SWITZERLAND ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 223 SWITZERLAND BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 224 SWITZERLAND ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 225 SWITZERLAND ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 226 RUSSIA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 227 RUSSIA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 228 RUSSIA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 229 RUSSIA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 230 RUSSIA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 231 RUSSIA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 232 RUSSIA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 233 RUSSIA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 234 RUSSIA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 235 RUSSIA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 236 RUSSIA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 237 RUSSIA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 238 RUSSIA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 239 RUSSIA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 240 RUSSIA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 241 NETHERLANDS ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 242 NETHERLANDS ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 243 NETHERLANDS NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 244 NETHERLANDS HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 245 NETHERLANDS VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 246 NETHERLANDS ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 247 NETHERLANDS ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 248 NETHERLANDS INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 249 NETHERLANDS ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 250 NETHERLANDS CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 251 NETHERLANDS ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 252 NETHERLANDS ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 253 NETHERLANDS BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 254 NETHERLANDS ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 255 NETHERLANDS ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 256 BELGIUM ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 257 BELGIUM ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 258 BELGIUM NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 259 BELGIUM HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 260 BELGIUM VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 261 BELGIUM ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 262 BELGIUM ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 263 BELGIUM INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 264 BELGIUM ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 265 BELGIUM CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 266 BELGIUM ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 267 BELGIUM ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 268 BELGIUM BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 269 BELGIUM ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 270 BELGIUM ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 271 TURKEY ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 272 TURKEY ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 273 TURKEY NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 274 TURKEY HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 275 TURKEY VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 276 TURKEY ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 277 TURKEY ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 278 TURKEY INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 279 TURKEY ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 280 TURKEY CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 281 TURKEY ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 282 TURKEY ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 283 TURKEY BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 284 TURKEY ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 285 TURKEY ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 286 REST OF EUROPE ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 287 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 288 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 289 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 290 ASIA-PACIFIC NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 291 ASIA-PACIFIC HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 292 ASIA-PACIFIC VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 293 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 294 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 295 ASIA-PACIFIC INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 296 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 297 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 298 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 299 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 300 ASIA-PACIFIC BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION))
TABLE 301 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 302 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 303 JAPAN ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 304 JAPAN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 305 JAPAN NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 306 JAPAN HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 307 JAPAN VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 308 JAPAN ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 309 JAPAN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 310 JAPAN INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 311 JAPAN ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 312 JAPAN CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 313 JAPAN ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 314 JAPAN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 315 JAPAN BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 316 JAPAN ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 317 JAPAN ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 318 CHINA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 319 CHINA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 320 CHINA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 321 CHINA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 322 CHINA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 323 CHINA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 324 CHINA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 325 CHINA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 326 CHINA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 327 CHINA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 328 CHINA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 329 CHINA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 330 CHINA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 331 CHINA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 332 CHINA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 333 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 334 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 335 SOUTH KOREA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 336 SOUTH KOREA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 337 SOUTH KOREA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 338 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 339 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 340 SOUTH KOREA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 341 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 342 SOUTH KOREA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 343 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 344 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 345 SOUTH KOREA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 346 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 347 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 348 INDIA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 349 INDIA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 350 INDIA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 351 INDIA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 352 INDIA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 353 INDIA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 354 INDIA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 355 INDIA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 356 INDIA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 357 INDIA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 358 INDIA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 359 INDIA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 360 INDIA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 361 INDIA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 362 INDIA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 363 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 364 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 365 AUSTRALIA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 366 AUSTRALIA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 367 AUSTRALIA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 368 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 369 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 370 AUSTRALIA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 371 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 372 AUSTRALIA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 373 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 374 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 375 AUSTRALIA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 376 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 377 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 378 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 379 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 380 SINGAPORE NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 381 SINGAPORE HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 382 SINGAPORE VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 383 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 384 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 385 SINGAPORE INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 386 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 387 SINGAPORE CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 388 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 389 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 390 SINGAPORE BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 391 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 392 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 393 THAILAND ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 394 THAILAND ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 395 THAILAND NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 396 THAILAND HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 397 THAILAND VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 398 THAILAND ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 399 THAILAND ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 400 THAILAND INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 401 THAILAND ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 402 THAILAND CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 403 THAILAND ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 404 THAILAND ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 405 THAILAND BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 406 THAILAND ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 407 THAILAND ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 408 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 409 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 410 MALAYSIA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 411 MALAYSIA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 412 MALAYSIA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 413 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 414 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 415 MALAYSIA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 416 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 417 MALAYSIA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 418 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 419 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 420 MALAYSIA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 421 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 422 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 423 INDONESIA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 424 INDONESIA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 425 INDONESIA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 426 INDONESIA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 427 INDONESIA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 428 INDONESIA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 429 INDONESIA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 430 INDONESIA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 431 INDONESIA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 432 INDONESIA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 433 INDONESIA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 434 INDONESIA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 435 INDONESIA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 436 INDONESIA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 437 INDONESIA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 438 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 439 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 440 PHILIPPINES NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 441 PHILIPPINES HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 442 PHILIPPINES VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 443 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 444 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 445 PHILIPPINES INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 446 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 447 PHILIPPINES CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 448 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 449 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 450 PHILIPPINES BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 451 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 452 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 453 REST OF ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 454 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 455 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 456 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 457 SOUTH AMERICA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 458 SOUTH AMERICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 459 SOUTH AMERICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 460 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 461 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 462 SOUTH AMERICA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 463 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 464 SOUTH AMERICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 465 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 466 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 467 SOUTH AMERICA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 468 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 469 SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 470 BRAZIL ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 471 BRAZIL ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 472 BRAZIL NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 473 BRAZIL HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 474 BRAZIL VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 475 BRAZIL ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 476 BRAZIL ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 477 BRAZIL INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 478 BRAZIL ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 479 BRAZIL CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 480 BRAZIL ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 481 BRAZIL ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 482 BRAZIL BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 483 BRAZIL ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 484 BRAZIL ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 485 REST OF SOUTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 486 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 487 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 488 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 489 MIDDLE EAST AND AFRICA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 490 MIDDLE EAST AND AFRICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 491 MIDDLE EAST AND AFRICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 492 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 493 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 494 MIDDLE EAST AND AFRICA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 495 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 496 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 497 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 498 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 499 MIDDLE EAST AND AFRICA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 500 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 501 MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 502 U.S. ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 503 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 504 SOUTH AFRICA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 505 SOUTH AFRICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 506 SOUTH AFRICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 507 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 508 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 509 SOUTH AFRICA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 510 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 511 SOUTH AFRICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 512 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 513 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 514 SOUTH AFRICA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 515 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 516 SOUTH AFRICA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 517 REST OF MIDDLE EAST AND AFRICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)